VWF and hematologic disorder: It is a 26S proteasome inhibitor, used mainly in the treatment of hematological malignancies, but also works by inhibiting the activity of ADAMTS-13 metalloproteinase, also known as von Willebrand factor (vWF) cleavage protein, contributing to improve microcirculation [14].